Selected research
Industry Research
Parecoxib Sodium Industry Research Report 2026
Market perspective
The global Parecoxib Sodium market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Parecoxib Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Parecoxib Sodium is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Parecoxib Sodium is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Parecoxib Sodium include Sailong Pharma, Chiarai Tianqing, Qilu Pharma, Kelun Pharma and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Parecoxib Sodium market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Parecoxib Sodium Market by Company
Sailong Pharma
Chiarai Tianqing
Qilu Pharma
Kelun Pharma
Pfizer
Parecoxib Sodium Segment by Type
Original Drug
Generic Drug
Parecoxib Sodium Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Parecoxib Sodium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parecoxib Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Parecoxib Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parecoxib Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Parecoxib Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Parecoxib Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Parecoxib Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Original Drug
- Generic Drug
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Sailong Pharma
- Chiarai Tianqing
- Qilu Pharma
- Kelun Pharma
- Pfizer
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Parecoxib Sodium Market Size (2021-2032)
- 2.2.2 Global Parecoxib Sodium Sales (2021-2032)
- 2.2.3 Global Parecoxib Sodium Market Average Price (2021-2032)
- 2.3 Parecoxib Sodium by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Original Drug
- 2.3.3 Generic Drug
- 2.4 Parecoxib Sodium by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Parecoxib Sodium Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Parecoxib Sodium Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Parecoxib Sodium Revenue of Manufacturers (2021-2026)
- 3.4 Global Parecoxib Sodium Average Price by Manufacturers (2021-2026)
- 3.5 Global Parecoxib Sodium Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Parecoxib Sodium, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Parecoxib Sodium, Product Type & Application
- 3.8 Global Manufacturers of Parecoxib Sodium, Established Date
- 3.9 Global Parecoxib Sodium Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sailong Pharma
- 4.1.1 Sailong Pharma Company Information
- 4.1.2 Sailong Pharma Business Overview
- 4.1.3 Sailong Pharma Parecoxib Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sailong Pharma Parecoxib Sodium Product Portfolio
- 4.1.5 Sailong Pharma Recent Developments
- 4.2 Chiarai Tianqing
- 4.2.1 Chiarai Tianqing Company Information
- 4.2.2 Chiarai Tianqing Business Overview
- 4.2.3 Chiarai Tianqing Parecoxib Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Chiarai Tianqing Parecoxib Sodium Product Portfolio
- 4.2.5 Chiarai Tianqing Recent Developments
- 4.3 Qilu Pharma
- 4.3.1 Qilu Pharma Company Information
- 4.3.2 Qilu Pharma Business Overview
- 4.3.3 Qilu Pharma Parecoxib Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Qilu Pharma Parecoxib Sodium Product Portfolio
- 4.3.5 Qilu Pharma Recent Developments
- 4.4 Kelun Pharma
- 4.4.1 Kelun Pharma Company Information
- 4.4.2 Kelun Pharma Business Overview
- 4.4.3 Kelun Pharma Parecoxib Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Kelun Pharma Parecoxib Sodium Product Portfolio
- 4.4.5 Kelun Pharma Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Parecoxib Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Parecoxib Sodium Product Portfolio
- 4.5.5 Pfizer Recent Developments
5 Global Parecoxib Sodium Market Scenario by Region
- 5.1 Global Parecoxib Sodium Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Parecoxib Sodium Sales by Region: 2021-2032
- 5.2.1 Global Parecoxib Sodium Sales by Region: 2021-2026
- 5.2.2 Global Parecoxib Sodium Sales by Region: 2027-2032
- 5.3 Global Parecoxib Sodium Revenue by Region: 2021-2032
- 5.3.1 Global Parecoxib Sodium Revenue by Region: 2021-2026
- 5.3.2 Global Parecoxib Sodium Revenue by Region: 2027-2032
- 5.4 North America Parecoxib Sodium Market Facts & Figures by Country
- 5.4.1 North America Parecoxib Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Parecoxib Sodium Sales by Country (2021-2032)
- 5.4.3 North America Parecoxib Sodium Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Parecoxib Sodium Market Facts & Figures by Country
- 5.5.1 Europe Parecoxib Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Parecoxib Sodium Sales by Country (2021-2032)
- 5.5.3 Europe Parecoxib Sodium Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Parecoxib Sodium Market Facts & Figures by Country
- 5.6.1 Asia Pacific Parecoxib Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Parecoxib Sodium Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Parecoxib Sodium Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Parecoxib Sodium Market Facts & Figures by Country
- 5.7.1 South America Parecoxib Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Parecoxib Sodium Sales by Country (2021-2032)
- 5.7.3 South America Parecoxib Sodium Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Parecoxib Sodium Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Parecoxib Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Parecoxib Sodium Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Parecoxib Sodium Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Parecoxib Sodium Sales by Type (2021-2032)
- 6.1.1 Global Parecoxib Sodium Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Parecoxib Sodium Sales Market Share by Type (2021-2032)
- 6.2 Global Parecoxib Sodium Revenue by Type (2021-2032)
- 6.2.1 Global Parecoxib Sodium Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Parecoxib Sodium Revenue Market Share by Type (2021-2032)
- 6.3 Global Parecoxib Sodium Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Parecoxib Sodium Sales by Application (2021-2032)
- 7.1.1 Global Parecoxib Sodium Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Parecoxib Sodium Sales Market Share by Application (2021-2032)
- 7.2 Global Parecoxib Sodium Revenue by Application (2021-2032)
- 7.2.1 Global Parecoxib Sodium Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Parecoxib Sodium Revenue Market Share by Application (2021-2032)
- 7.3 Global Parecoxib Sodium Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Parecoxib Sodium Value Chain Analysis
- 8.1.1 Parecoxib Sodium Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Parecoxib Sodium Production Mode & Process
- 8.2 Parecoxib Sodium Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Parecoxib Sodium Distributors
- 8.2.3 Parecoxib Sodium Customers
9 Global Parecoxib Sodium Analyzing Market Dynamics
- 9.1 Parecoxib Sodium Industry Trends
- 9.2 Parecoxib Sodium Industry Drivers
- 9.3 Parecoxib Sodium Industry Opportunities and Challenges
- 9.4 Parecoxib Sodium Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst